Atomoxetine affects transcription/translation of the NMDA receptor and the norepinephrine transporter in the rat brain – an in vivo study

References

• Polanczyk G de Lima MS Horta BL Biederman J Rohde LA The worldwide prevalence of ADHD: a systematic review and metaregression analysis Am J Psychiatry 2007 164 6 942 948 17541055
   PubMed Web of Science ®Google Scholar
• Biederman J Faraone SV Attention-deficit hyperactivity disorder Lancet 2005 366 9481 237 248 16023516
   PubMed Web of Science ®Google Scholar
• Spencer TJ Biederman J Mick E Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology J Pediatr Psychol 2007 32 6 631 642 17556405
   PubMed Web of Science ®Google Scholar
• Kessler RC Adler L Barkley R The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication Am J Psychiatry 2006 163 4 716 723 16585449
   PubMed Web of Science ®Google Scholar
• Stahl S Attention deficit hyperactivity disorder and its treatmented Stahl S Stahl’s Essential Psychopharmacocogy 3rd ed New York, NY Cambridge University Press 2008 863 897
   Google Scholar
• Gibson AP Bettinger TL Patel NC Crismon ML Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder Ann Pharmacother 2006 40 6 1134 1142 16735655
   PubMed Web of Science ®Google Scholar
• Molina BS Hinshaw SP Swanson JM MTA Cooperative Group The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study J Am Acad Child Adolesc Psychiatry 2009 48 5 484 500 19318991
   PubMed Web of Science ®Google Scholar
• Ferris RM Tang FL Maxwell RA A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta J Pharmacol Exp Ther 1972 181 3 407 416 5033010
   PubMed Web of Science ®Google Scholar
• Schweri MM Skolnick P Rafferty MF Rice KC Janowsky AJ Paul SM [3H]Threo-(+/−)-methylphenidate binding to 3,4-dihydroxyphenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters J Neurochem 1985 45 4 1062 1070 4031878
   PubMed Web of Science ®Google Scholar
• Carrey NJ MacMaster FP Gaudet L Schmidt MH Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder J Child Adolesc Psychopharmacol 2007 17 1 11 17 17343550
   PubMed Web of Science ®Google Scholar
• Lule D Ludolph AC Ludolph AG Neurodevelopmental and neurodegenerative diseases – is there a pathophysiological link? Attention-deficit/hyperactivity disorder and amyotrophic lateral sclerosis as examples Med Hypotheses 2008 70 6 1133 1138 18158219
   PubMed Web of Science ®Google Scholar
• Orrego F Villanueva S The chemical nature of the main central excitatory transmitter: a critical appraisal based upon release studies and synaptic vesicle localization Neuroscience 1993 56 3 539 555 7902967
   PubMed Web of Science ®Google Scholar
• Davies J Evans RH Francis AA Watkins JC Excitatory amino acid receptors and synaptic excitation in the mammalian central nervous system J Physiol (Paris) 1979 75 6 641 654 232719
   PubMedGoogle Scholar
• Cull-Candy S Brickley S Farrant M NMDA receptor subunits: diversity, development and disease Curr Opin Neurobiol 2001 11 3 327 335 11399431
   PubMed Web of Science ®Google Scholar
• Köhr G Jensen V Koester HJ Intracellular domains of NMDA receptor subtypes are determinants for long-term potentiation induction J Neurosci 2003 23 34 10791 10799 14645471
   PubMed Web of Science ®Google Scholar
• Monyer H Burnashev N Laurie DJ Sakmann B Seeburg PH Developmental and regional expression in the rat brain and functional properties of four NMDA receptors Neuron 1994 12 3 529 540 7512349
   PubMed Web of Science ®Google Scholar
• Stocca G Vicini S Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons J Physiol 1998 507 Pt 1 13 24 9490809
   PubMed Web of Science ®Google Scholar
• Tovar KR Westbrook GL The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro J Neurosci 1999 19 10 4180 4188 10234045
   PubMed Web of Science ®Google Scholar
• Li B Chen N Luo T Otsu Y Murphy TH Raymond LA Differential regulation of synaptic and extra-synaptic NMDA receptors Nat Neurosci 2002 5 9 833 834 12195433
   PubMed Web of Science ®Google Scholar
• Köhr G NMDA receptor function: subunit composition versus spatial distribution Cell Tissue Res 2006 326 2 439 446 16862427
   PubMed Web of Science ®Google Scholar
• Hardingham GE Fukunaga Y Bading H Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways Nat Neurosci 2002 5 5 405 414 11953750
   PubMed Web of Science ®Google Scholar
• Jensen V Rinholm JE Johansen TJ N-methyl-D-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder Neuroscience 2009 158 1 353 364 18571865
   PubMed Web of Science ®Google Scholar
• Malinow R Malenka RC AMPA receptor trafficking and synaptic plasticity Annu Review Neurosci 2002 25 103 126
   PubMed Web of Science ®Google Scholar
• Bredt DS Nicoll RA AMPA receptor trafficking at excitatory synapses Neuron 2003 40 2 361 379 14556714
   PubMed Web of Science ®Google Scholar
• Lou HC Etiology and pathogenesis of attention-deficit hyperactivity disorder (ADHD): significance of prematurity and perinatal hypoxic-haemodynamic encephalopathy Acta Paediatr 1996 85 11 1266 1271 8955450
   PubMed Web of Science ®Google Scholar
• Gehlert DR Schober DA Gackenheimer SL Comparison of (R)-[3H] tomoxetine and (R/S)-[3H]nisoxetine binding in rat brain J Neurochem 1995 64 6 2792 2800 7760060
   PubMed Web of Science ®Google Scholar
• Bymaster FP Katner JS Nelson DL Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder Neuropsychopharmacology 2002 27 5 699 711 12431845
   PubMed Web of Science ®Google Scholar
• Easton N Steward C Marshall F Fone K Marsden C Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain Neuropharmacology 2007 52 2 405 414 17020775
   PubMed Web of Science ®Google Scholar
• Peterson K McDonagh MS Fu R Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis Psychopharmacology (Berl) 2008 197 1 1 11 18026719
   PubMed Web of Science ®Google Scholar
• Seneca N Gulyás B Varrone A Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2 Psychopharmacology (Berl) 2006 188 1 119 127 16896954
   PubMed Web of Science ®Google Scholar
• Takano A Gulyás B Varrone A Maguire RP Halldin C Saturated norepinephrine transporter occupancy by atomoxetine relevant to clinical doses: a rhesus monkey study with (S,S)-[(18)F]FMeNER-D (2) Eur J Nucl Med Mol Imaging 2009 36 8 1308 1314 19300997
   PubMed Web of Science ®Google Scholar
• Kratochvil CJ Heiligenstein JH Dittmann R Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial J Am Acad Child Adolesc Psychiatry 2002 41 7 776 784 12108801
   PubMed Web of Science ®Google Scholar
• Hiemke C Baumann P Bergemann N AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011 Pharmacopsychiatry 2011 44 6 195 235
   Web of Science ®Google Scholar
• Kielbasa W Kalvass JC Stratford R Microdialysis evaluation of atomoxetine brain penetration and central nervous system pharmacokinetics in rats Drug Metab Dispos 2009 37 1 137 142 18936112
   PubMed Web of Science ®Google Scholar
• Scherer D Hassel D Bloehs R Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents Br J Pharmacol 2009 156 2 226 236 19154426
   PubMed Web of Science ®Google Scholar
• Ludolph AG Udvardi PT Schaz U Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations Br J Pharmacol 2010 160 2 283 291 20423340
   PubMed Web of Science ®Google Scholar
• Lempp T Toennes SW Wunder C Altered gene expression in the prefrontal cortex of young rats induced by the ADHD drug atomoxetine Prog Neuropsychopharmacol Biol Psychiatry 2013 40 221 228 22960082
   PubMed Web of Science ®Google Scholar
• Ikonomidou C Bittigau P Koch C Neurotransmitters and apoptosis in the developing brain Biochem Pharmacol 2001 62 4 401 405 11448448
   PubMed Web of Science ®Google Scholar
• Paxinos G Watson C The Rat Brain: In Stereotactic Coordinates 2nd Ed London Academic Press 1986
   Google Scholar
• Vandesompele J De Preter K Pattyn F Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome biology. RESEARCH0034 2002 3 7
   Google Scholar
• Mestdagh P Van Vlierberghe P De Weer A A novel and universal method for microRNA RT-qPCR data normalization Genome biology 2009 10 6 R64 19531210
   PubMed Web of Science ®Google Scholar
• Schaffner W Weissmann C A rapid, sensitive, and specific method for the determination of protein in dilute solution Anal Biochem 1973 56 2 502 514 4128882
   PubMed Web of Science ®Google Scholar
• Aldridge GM Podrebarac DM Greenough WT Weiler IJ The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting J Neurosci Methods 2008 172 2 250 254 18571732
   PubMed Web of Science ®Google Scholar
• Bayles R Harikrishnan KN Lambert E Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome Arterioscler Thromb Vasc Biol 2012 32 8 1910 1916 22723437
   PubMed Web of Science ®Google Scholar
• Altafaj X Ortiz-Abalia J Fernández M Increased NR2A expression and prolonged decay of NMDA-induced calcium transient in cerebellum of TgDyrk1A mice, a mouse model of Down syndrome Neurobiol Dis 2008 32 3 377 384 18773961
   PubMed Web of Science ®Google Scholar
• Uriu Y Kiyonaka S Miki T Rab3-interacting molecule gamma isoforms lacking the Rab3-binding domain induce long lasting currents but block neurotransmitter vesicle anchoring in voltage-dependent P/Q-type Ca2+ channels J Biol Chem 2010 285 28 21750 21767 20452978
   PubMed Web of Science ®Google Scholar
• Chalazonitis A Tang AA Shang Y Homeodomain interacting protein kinase 2 regulates postnatal development of enteric dopaminergic neurons and glia via BMP signaling J Neurosci 2011 31 39 13746 13757 21957238
   PubMed Web of Science ®Google Scholar
• Michelson D Faries D Wernicke J Atomoxetine ADHD Study Group Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study Pediatrics 2001 108 5 E83 11694667
   PubMed Web of Science ®Google Scholar
• Gehlert DR Gackenheimer SL Robertson DW Localization of rat brain binding sites for [3H]tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sites Neurosci Lett 1993 157 2 203 206 8233054
   PubMed Web of Science ®Google Scholar
• Arcos-Burgos M Londoño AC Pineda DA Analysis of brain metabolism by proton magnetic resonance spectroscopy (1H-MRS) in attention-deficit/hyperactivity disorder suggests a generalized differential ontogenic pattern from controls Atten Defic Hyperact Disord 2012 4 4 205 212 23012086
   PubMedGoogle Scholar
• Wiguna T Guerrero APS Wibisono S Sastroasmoro S Effect of 12-week administration of 20-mg long-acting methylphenidate on Glu/Cr, NAA/Cr, Cho/Cr, and mI/Cr ratios in the prefrontal cortices of school-age children in Indonesia: a study using 1H magnetic resonance spectroscopy (MRS) Clin Neuropharmacol 2012 35 2 81 85 22318191
   PubMed Web of Science ®Google Scholar
• Carrey N MacMaster FP Fogel J Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study Clin Neuropharmacol 2003 26 4 218 221 12897644
   PubMed Web of Science ®Google Scholar
• Tafazoli S O’Neill J Bejjani A 1H MRSI of middle frontal gyrus in pediatric ADHD J Psychiatr Res 2013 47 4 505 512 23273650
   PubMed Web of Science ®Google Scholar
• Duguid IC Smart TG Presynaptic NMDAR receptors VanDongen AM Biology of the NMDAR Receptor Boca Raton, FL CRC Press 2009 313 328
   Google Scholar
• Langer SZ Presynaptic autoreceptors regulating transmitter release Neurochem Int 2008 52 1–2 26 30 17583385
   PubMed Web of Science ®Google Scholar
• Stevens CF Presynaptic function Curr Opin Neurobiol 2004 14 3 341 345 15194114
   PubMed Web of Science ®Google Scholar
• Sudhof TC The synaptic vesicle cycle Annu Rev Neurosci 2004 27 509 547 15217342
   PubMed Web of Science ®Google Scholar
• Pittaluga A Raiteri M N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. III. Changes in the NMDA receptor complex induced by their functional cooperation J Pharmacol Exp Ther 1992 263 1 327 333 1357159
   PubMed Web of Science ®Google Scholar
• Rammes G Mahal B Putzke J The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801 Neuropharmacology 2001 40 6 749 760 11369029
   PubMed Web of Science ®Google Scholar
• Sheng M Cummings J Roldan LA Jan YN Jan LY Changing subunit composition of heteromeric NMDA receptors during development of rat cortex Nature 1994 368 6467 144 147 8139656
   PubMed Web of Science ®Google Scholar
• Wenzel A Fritschy JM Mohler H Benke D NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins J Neurochem 1997 68 2 469 478 9003031
   PubMed Web of Science ®Google Scholar
• Barria A Malinow R NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII Neuron 2005 48 2 289 301 16242409
   PubMed Web of Science ®Google Scholar
• Martin D Bustos GA Bowe MA Bray SD Nadler JV Autoreceptor regulation of glutamate and aspartate release from slices of the hippocampal CA1 area J Neurochem 1991 56 5 1647 1655 1672884
   PubMed Web of Science ®Google Scholar
• Paoletti P Neyton J NMDA receptor subunits: function and pharmacology Curr Opin Pharmacol 2007 7 1 39 47 17088105
   PubMed Web of Science ®Google Scholar
• Guo Y Xiao P Lei S How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes Acta Biochim Biophys Sin (Shanghai) 2008 40 5 426 436 18465028
   PubMed Web of Science ®Google Scholar
• MacMaster FP Carrey N Sparkes S Kusumakar V Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder Biol Psychiatry 2003 53 2 184 187 12547476
   PubMed Web of Science ®Google Scholar
• Ikonomidou C Bosch F Miksa M Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain Science 1999 283 5398 70 74 9872743
   PubMed Web of Science ®Google Scholar
• Findling RL Short EJ McNamara NK Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 2007 46 11 1445 1453 18049294
   PubMed Web of Science ®Google Scholar
• Standaert DG Testa CM Young AB Penney JB Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat J Comp Neurol 1994 343 1 1 16 8027428
   PubMed Web of Science ®Google Scholar
• Puliti A Rossi PI Caridi G Albuminuria and glomerular damage in mice lacking the metabotropic glutamate receptor 1 Am J Pathol 2011 178 3 1257 1269 21356376
   PubMed Web of Science ®Google Scholar
• Neale BM Lasky-Su J Anney R Genome-wide association scan of attention deficit hyperactivity disorder Am J Med Genet B Neuropsychiatr Genet 2008 147B 8 1337 1344 18980221
   PubMed Web of Science ®Google Scholar
• Lesch KP Timmesfeld N Renner TJ Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies J Neural Transm 2008 115 11 1573 1585 18839057
   PubMed Web of Science ®Google Scholar
• Romanos M Freitag C Jacob C Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12 Mol Psychiatry 2008 13 5 522 530 18301393
   PubMed Web of Science ®Google Scholar
• Franke B Neale BM Faraone SV Genome-wide association studies in ADHD Hum Genet 2009 126 1 13 50 19384554
   PubMed Web of Science ®Google Scholar
• Poelmans G Pauls DL Buitelaar JK Franke B Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder Am J Psychiatry 2011 168 4 365 377 21324949
   PubMed Web of Science ®Google Scholar
• Ramocki MB Zoghbi HY Failure of neuronal homeostasis results in common neuropsychiatric phenotypes Nature 2008 455 7215 912 918 18923513
   PubMed Web of Science ®Google Scholar
• Hess EJ Jinnah HA Kozak CA Wilson MC Spontaneous locomotor hyperactivity in a mouse mutant with a deletion including the Snap gene on chromosome 2 J Neurosci 1992 12 7 2865 2874 1613559
   PubMed Web of Science ®Google Scholar
• Hess EJ Collins KA Wilson MC Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation J Neurosci 1996 16 9 3104 3111 8622140
   PubMed Web of Science ®Google Scholar
• Sagvolden T Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD) Neurosci Biobehav Rev 2000 24 1 31 39 10654658
   PubMed Web of Science ®Google Scholar
• Sagvolden T Johansen EB Aase H Russell VA A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes Behav Brain Sci 2005 28 3 397 419 discussion 419–468 16209748
   PubMed Web of Science ®Google Scholar